Roche Holding Ltd. Stock Swiss Exchange
Stocks
CH0012032048
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Swiss Exchange
|
||
| - CHF | - |
|
| 09-13 | Roche Outlines Positive Phase 3 Trial Data for Small-cell Lung Cancer Treatment in China | MT |
| 09-11 | Scholar Rock gets first FDA nod for rare muscle-wasting disease (September 11) | RE |
| Market Cap | 289B 348B 306B 263B 492B 33,383B 496B 3,454B 1,338B 17,055B 1,308B 1,279B 54,813B | P/E 2026 * |
19.6x | P/E 2027 * | 17.7x |
|---|---|---|---|---|---|
| Enterprise Value | 300B 361B 317B 273B 511B 34,639B 515B 3,584B 1,388B 17,697B 1,357B 1,328B 56,875B | EV / Sales 2026 * |
4.78x | EV / Sales 2027 * | 4.47x |
| Free-Float |
88.78% | Yield 2026 * |
2.78% | Yield 2027 * | 2.85% |
Last Transcript: Roche Holding Ltd.
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 2023-03-14 | |
Alan Hippe
DFI | Director of Finance/CFO | 59 | 2011-06-05 |
| Chief Operating Officer | - | 2025-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
André Hoffmann
BRD | Director/Board Member | 68 | 1995-12-31 |
Severin Schwan
CHM | Chairman | 59 | 2023-03-14 |
| Director/Board Member | 73 | 2015-03-02 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.13% | +2.65% | +65.61% | +114.28% | 1,055B | |
| +0.20% | +0.46% | +52.60% | +69.24% | 654B | |
| -0.29% | +0.14% | +20.96% | +70.93% | 467B | |
| -0.85% | +0.98% | +41.29% | +44.38% | 348B | |
| +0.71% | +4.08% | +22.24% | +29.51% | 275B | |
| +1.23% | +0.42% | +14.57% | +12.13% | 258B | |
| +2.11% | +7.51% | +52.89% | +55.37% | 224B | |
| +0.83% | +0.55% | +35.99% | +101.70% | 187B | |
| 0.00% | -10.14% | -29.94% | -60.30% | 171B | |
| Average | +0.36% | +0.74% | +30.69% | +48.58% | 404.26B | |
| Weighted average by Cap. | +0.02% | +1.32% | +41.54% | +67.83% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 62.66B 75.6B 66.34B 57.1B 107B 7,246B 108B 750B 290B 3,702B 284B 278B 11,898B | 65.47B 79B 69.32B 59.67B 112B 7,572B 112B 784B 303B 3,868B 297B 290B 12,432B |
| Net income | 14.51B 17.5B 15.36B 13.22B 24.75B 1,678B 24.92B 174B 67.23B 857B 65.72B 64.3B 2,754B | 16.33B 19.7B 17.29B 14.88B 27.86B 1,889B 28.06B 195B 75.69B 965B 73.98B 72.38B 3,101B |
| Net Debt | 10.86B 13.1B 11.5B 9.9B 18.53B 1,256B 18.66B 130B 50.33B 642B 49.2B 48.14B 2,062B | 3.99B 4.82B 4.23B 3.64B 6.81B 462B 6.86B 47.8B 18.51B 236B 18.1B 17.71B 759B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
